Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently published a groundbreaking analysis on the use of artificial intelligence and machine learning (AI/ML) in drug therapy decisions. This marks …
FDA Utilizes AI/ML for Drug Therapy Decision-Making Read More
MALVERN, PA — YPrime has launched its cutting-edge eCOA 7.0 SaaS platform, poised to transform the clinical trial industry. This launch reflects YPrime’s dedication to integrating advanced technology with user-centric …
YPrime Unveils Revolutionary eCOA 7.0 Platform Read More WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently issued a draft guidance aimed at improving the clinical development of drugs to treat pediatric patients with inflammatory bowel disease …
FDA Issues New Guidance for Pediatric Inflammatory Bowel Disease Drug Development Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) released new guidelines aimed at improving treatment options for young children with partial onset seizures (POS). The guidance, titled …
FDA Issues New Guidance on Epilepsy Drugs for Young Children Read More MALVERN, PA — YPrime has released a research report titled “Endocrinology Clinical Trials: Advancing Research with the Help of eCOA Technologies.” This report, derived from a survey of clinical trial …
YPrime’s New Report Highlights Role of eCOA Technologies in Endocrinology Clinical Trials Read More
PHILADELPHIA, PA — Trial Equity has partnered with Miller Tanner Associates (MTA) in a bid to enhance education and participation among diverse patient groups in clinical trials. This collaboration targets …
Trial Equity and MTA Join Forces to Boost Clinical Trial Diversity Read More MALVERN, PA — YPrime has unveiled a new glucometer functionality that integrates seamlessly with its electronic Clinical Outcome Assessment (eCOA) platform. This innovation, developed alongside diabetes patients, aims to revolutionize …
YPrime Launches Groundbreaking Glucometer Feature for Clinical Trials Read More
PLYMOUTH MEETING, PA — Biotechnology company INOVIO (NASDAQ: INO) is making considerable strides with its lead program, INO-3107, aimed at addressing Recurrent Respiratory Papillomatosis (RRP). This progress, backed by encouraging …
Innovation Meets Acceleration: INOVIO Advances in Treatment for Respiratory Disease and Beyond Read More
BERWYN, PA — In a move to promote diversity in clinical trials, Chester County-based Mural Health has announced the “Harley Jacobsen Clinical Trial Participation Income Exemption Act,” a landmark legislation …
Mural Health Champions Revolutionary Bill for Enhanced Diversity in Clinical Trials Read More